Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAbhishek karande

    Abhishek Karande

    Jump to

    • Bank of India may test Rs 265-270: Abhishek Karande

      Abhishek Karande of SBICAP Securities is of the view that Bank of India may test Rs 265-270.

    • Buy HDFC, advises Abhishek Karande

      Abhishek Karande of SBI Capital Securities recommends buying Housing Development Finance Corporation as the stock may test Rs 870-880.

    • Buy Reliance Industries, ONGC: Abhishek Karande

      Abhishek Karande of SBI Capital Securities is of the view that one may buy Reliance Industries and Oil and Natural Gas Corporation.

    • Buy Divis Laboratories on correction: Abhishek Karande

      Abhishek Karande of SBI Capital Securities is of the view that one may buy Divis Laboratories on correction as the stock may touch Rs 1400.

    • Pick Maruti Suzuki, advises Abhishek Karande

      Abhishek Karande of SBICapital Securities recommends to pick Maruti Suzuki India as the stock may test Rs 2000.

    • Sell BPCL, advises Abhishek Karande

      Abhishek Karande of SBICapital Securities recommends selling Bharat Petroleum Corporation as the stock may head lower and test Rs 300.

    • Accumulate Bharat Forge: Abhishek Karande

      Abhishek Karande of SBICapital Securities is of the view that one may accumulate Bharat Forge as the stock may head higher by 5-6 percent.

    • Buy Exide, Castrol India: Abhishek Karande

      Abhishek Karande of SBI Capital Securities recommends buying Exide Industries at current levels with a target of Rs 145-150.

    • Glenmark Pharma may move upto Rs 600: Abhishek Karande

      Abhishek Karande of SBI Capital Securities is of the view that Glenmark Pharma may move upto Rs 600.

    • Prefer Divis Labs, Ranbaxy, Maruti: Abhishek Karande

      Abhishek Karande of SBICAP Securities is of the view that one may prefer Cipla, Divi‘s Laboartories, Ranbaxy Laboratories within the pharmaceutical sector, and Maruti Suzuki India and Hero Motocorp within the automobile space.

    • Avoid Aurobindo Pharma: Abhishek Karande

      According to Abhishek Karande of SBICap Securities, one may avoid Aurobindo Pharma and advises picking Cipla or Divis Laboratories.

    • BPCL may touch Rs 300-310: Abhishek Karande

      Abhishek Karande of SBICap Securities is of the view that Bharat Petroleum Corporation may touch Rs 300-310.

    • Buy Sesa Sterlite: Abhishek Karande

      Abhishek Karande of SBICap Securities recommends buying Sesa Sterlite as the stock may test Rs 220-225.

    • Buy Cipla on correction, says Abhishek Karande

      Abhishek Karande of SBICap Securities recommends buying Cipla on correction as the stock may touch Rs 440.

    • Above Rs 300, Mcleod Russel may test Rs 335-340: Karande

      Abhishek Karande of SBI Cap Securities is of the view that Mcleod Russel (India) may test Rs 335-340 if it manages to cross Rs 300.

    • Buy Oil India, says Abhishek Karande

      Abhishek Karande of SBI Cap Securities recommends buying Oil India with a target of Rs 510.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347